Overview The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2 Status: Completed Trial end date: 2020-12-31 Target enrollment: Participant gender: Summary To evaluate a pharmacokinetic drug interaction between AJU-A51R1 and AJU-A51R2 in healthy male volunteers. Phase: Phase 1 Details Lead Sponsor: AJU Pharm Co., Ltd.